Johnson & Johnson Total Long Term Liabilities 2012-2026 | JNJ

Johnson & Johnson total long term liabilities for the quarter ending March 31, 2026 were $63.540B, a 9% increase year-over-year.

  • Johnson & Johnson total long term liabilities for 2025 were $63.54B, a 9% increase from 2024.
  • Johnson & Johnson total long term liabilities for 2024 were $58.293B, a 11.03% increase from 2023.
  • Johnson & Johnson total long term liabilities for 2023 were $52.502B, a 4.14% decline from 2022.

Johnson & Johnson Total Long Term Liabilities 2012-2026 | JNJ

  • Johnson & Johnson total long term liabilities for 2025 were $63.54B, a 9% increase from 2024.
  • Johnson & Johnson total long term liabilities for 2024 were $58.293B, a 11.03% increase from 2023.
  • Johnson & Johnson total long term liabilities for 2023 were $52.502B, a 4.14% decline from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B